{"id":"https://openalex.org/W2144997010","doi":"https://doi.org/10.1002/j.1552-4604.1993.tb04669.x","title":"Pharmacokinetics of Clentiazem After Intravenous and Oral Administration in Healthy Subjects","display_name":"Pharmacokinetics of Clentiazem After Intravenous and Oral Administration in Healthy Subjects","publication_year":1993,"publication_date":"1993-04-01","ids":{"openalex":"https://openalex.org/W2144997010","doi":"https://doi.org/10.1002/j.1552-4604.1993.tb04669.x","mag":"2144997010","pmid":"https://pubmed.ncbi.nlm.nih.gov/8473551"},"language":"en","primary_location":{"id":"doi:10.1002/j.1552-4604.1993.tb04669.x","doi":"https://doi.org/10.1002/j.1552-4604.1993.tb04669.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1552-4604.1993.tb04669.x","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ajit K. Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ajit K. Shah","raw_affiliation_strings":["Marion Merrell Dow Inc., Kansas City, Missouri 64134-0627"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marion Merrell Dow Inc., Kansas City, Missouri 64134-0627","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023954017","display_name":"Vijay O. Bhargava","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I22751591","display_name":"Kansas City Art Institute","ror":"https://ror.org/05tbkx115","country_code":"US","type":"education","lineage":["https://openalex.org/I22751591"]},{"id":"https://openalex.org/I4210128345","display_name":"Kansas City Public Schools","ror":"https://ror.org/03pvzeb17","country_code":"US","type":"education","lineage":["https://openalex.org/I4210128345"]},{"id":"https://openalex.org/I4210148595","display_name":"Kansas City Public Library","ror":"https://ror.org/04pwkqp57","country_code":"US","type":"archive","lineage":["https://openalex.org/I4210148595"]},{"id":"https://openalex.org/I4387155069","display_name":"Kansas City National Security Campus","ror":"https://ror.org/03e7mhc87","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I4387155069"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vijay O. Bhargava","raw_affiliation_strings":["Marion Merrell Dow, Inc. Kansas City, Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marion Merrell Dow, Inc. Kansas City, Missouri","institution_ids":["https://openalex.org/I22751591","https://openalex.org/I4210128345","https://openalex.org/I4210148595","https://openalex.org/I4387155069"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002299630","display_name":"Scott James Weir","orcid":"https://orcid.org/0000-0002-8020-434X","observed_orcids":["https://orcid.org/0000-0002-8020-434X"]},"institutions":[{"id":"https://openalex.org/I22751591","display_name":"Kansas City Art Institute","ror":"https://ror.org/05tbkx115","country_code":"US","type":"education","lineage":["https://openalex.org/I22751591"]},{"id":"https://openalex.org/I4210128345","display_name":"Kansas City Public Schools","ror":"https://ror.org/03pvzeb17","country_code":"US","type":"education","lineage":["https://openalex.org/I4210128345"]},{"id":"https://openalex.org/I4210148595","display_name":"Kansas City Public Library","ror":"https://ror.org/04pwkqp57","country_code":"US","type":"archive","lineage":["https://openalex.org/I4210148595"]},{"id":"https://openalex.org/I4387155069","display_name":"Kansas City National Security Campus","ror":"https://ror.org/03e7mhc87","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I4387155069"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott J. Weir","raw_affiliation_strings":["Marion Merrell Dow, Inc. Kansas City, Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marion Merrell Dow, Inc. Kansas City, Missouri","institution_ids":["https://openalex.org/I22751591","https://openalex.org/I4210128345","https://openalex.org/I4210148595","https://openalex.org/I4387155069"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033482346","display_name":"Dennis H. Giesing","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I22751591","display_name":"Kansas City Art Institute","ror":"https://ror.org/05tbkx115","country_code":"US","type":"education","lineage":["https://openalex.org/I22751591"]},{"id":"https://openalex.org/I4210128345","display_name":"Kansas City Public Schools","ror":"https://ror.org/03pvzeb17","country_code":"US","type":"education","lineage":["https://openalex.org/I4210128345"]},{"id":"https://openalex.org/I4210148595","display_name":"Kansas City Public Library","ror":"https://ror.org/04pwkqp57","country_code":"US","type":"archive","lineage":["https://openalex.org/I4210148595"]},{"id":"https://openalex.org/I4387155069","display_name":"Kansas City National Security Campus","ror":"https://ror.org/03e7mhc87","country_code":"US","type":"facility","lineage":["https://openalex.org/I1330989302","https://openalex.org/I4387155069"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dennis H. Giesing","raw_affiliation_strings":["Marion Merrell Dow, Inc. Kansas City, Missouri"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Marion Merrell Dow, Inc. Kansas City, Missouri","institution_ids":["https://openalex.org/I22751591","https://openalex.org/I4210128345","https://openalex.org/I4210148595","https://openalex.org/I4387155069"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.15887097,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"33","issue":"4","first_page":"354","last_page":"359"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.951200008392334,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clentiazem","display_name":"clentiazem","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9480000138282776},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.8690000176429749},{"id":"https://openalex.org/keywords/oral-administration","display_name":"oral administration","score":0.9950000047683716},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7929999828338623},{"id":"https://openalex.org/keywords/first-pass-metabolism","display_name":"first-pass metabolism","score":0.8759999871253967},{"id":"https://openalex.org/keywords/drug-metabolites","display_name":"drug metabolites","score":0.7269999980926514},{"id":"https://openalex.org/keywords/clearance","display_name":"clearance","score":0.5350000262260437},{"id":"https://openalex.org/keywords/volume-of-distribution","display_name":"volume of distribution","score":0.9929999709129333},{"id":"https://openalex.org/keywords/half-life","display_name":"half-life","score":0.9319999814033508},{"id":"https://openalex.org/keywords/mean-residence-time","display_name":"mean residence time","score":0.7590000033378601},{"id":"https://openalex.org/keywords/absorption-time","display_name":"absorption time","score":0.6970000267028809},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.8550000190734863}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8804690837860107},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.7471321225166321},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.6871022582054138},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.6429022550582886},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5928624868392944},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.5879775285720825},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5343493819236755},{"id":"https://openalex.org/C3941253","wikidata":"https://www.wikidata.org/wiki/Q47270","display_name":"Half-life","level":3,"score":0.5335664749145508},{"id":"https://openalex.org/C3020190219","wikidata":"https://www.wikidata.org/wiki/Q640448","display_name":"Intravenous bolus","level":2,"score":0.4915219247341156},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.4894944429397583},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4299044907093048},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3857976198196411},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22165441513061523},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0714339017868042},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004110","descriptor_name":"Diltiazem","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/j.1552-4604.1993.tb04669.x","doi":"https://doi.org/10.1002/j.1552-4604.1993.tb04669.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1552-4604.1993.tb04669.x","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:8473551","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8473551","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":10,"referenced_works":["https://openalex.org/W2016394123","https://openalex.org/W2038013275","https://openalex.org/W2093741738","https://openalex.org/W2159435564","https://openalex.org/W2332733959","https://openalex.org/W2404172510","https://openalex.org/W2412957531","https://openalex.org/W2422782238","https://openalex.org/W2502670554","https://openalex.org/W4232319073"],"related_works":["https://openalex.org/W2916373397","https://openalex.org/W2038013275","https://openalex.org/W2008227560","https://openalex.org/W2082487182","https://openalex.org/W1990903458","https://openalex.org/W1997791214","https://openalex.org/W36825362","https://openalex.org/W144174057","https://openalex.org/W2140213697","https://openalex.org/W2136707390"],"abstract_inverted_index":{"This":[0],"study":[1],"characterized":[2],"the":[3,64,153],"pharmacokinetics":[4],"of":[5,41,45,63,90,96,142,150,155,160,187,202],"clentiazem":[6],"(CLZ)":[7],"after":[8,61,110,136,166,171],"a":[9,46,76,133,175,209],"single":[10],"intravenous":[11],"bolus":[12],"(IV)":[13],"and":[14,36,72,94,105,119,127,183,193],"oral":[15],"(PO)":[16],"dose":[17],"in":[18],"humans.":[19],"Twenty-four":[20],"healthy":[21],"male":[22],"subjects":[23],"(28.5":[24],"+/-":[25,29],"5.2":[26],"years;":[27],"77":[28],"8.2":[30],"kg)":[31],"received":[32],"IV":[33,111,167],"(20":[34],"mg)":[35,39],"PO":[37,137,143,172],"(80":[38],"doses":[40],"CLZ":[42,71,97,116,144,157,161,188,203],"as":[43],"part":[44],"four-way,":[47],"randomized,":[48],"complete":[49],"crossover":[50],"study.":[51],"Serial":[52],"blood":[53],"samples":[54,67],"were":[55,68,98,123,189],"drawn":[56],"up":[57],"to":[58,121,158,168],"48":[59],"hours":[60,107,129,191,195],"administration":[62],"drug.":[65],"Plasma":[66],"analyzed":[69],"for":[70,86],"three":[73],"metabolites":[74],"by":[75,207],"high-pressure":[77],"liquid":[78],"chromatography":[79],"method.":[80],"The":[81,113,139,148,179,198],"values":[82],"(mean":[83],"[CV,":[84],"%])":[85],"systemic":[87],"clearance,":[88],"volume":[89],"distribution":[91],"at":[92],"steady-state,":[93],"half-life":[95],"63.6":[99],"L/hour":[100],"(23.5),":[101],"756.1":[102],"L":[103],"(19.1),":[104],"10.6":[106],"(33.1),":[108],"respectively,":[109,131],"administration.":[112,138],"peak":[114],"plasma":[115,199],"concentration":[117],"(Cmax)":[118],"time":[120,135,182,186],"Cmax":[122],"37.0":[124],"ng/mL":[125],"(38.7)":[126],"3.7":[128],"(22.9),":[130],"with":[132],"lag":[134],"absolute":[140],"bioavailability":[141],"was":[145],"45%":[146],"(30.7).":[147],"ratio":[149],"area":[151],"under":[152],"curve":[154],"N-desmethyl":[156],"that":[159],"increased":[162],"from":[163],"0.15":[164],"(57.0)":[165],"0.60":[169],"(21.4)":[170],"administration,":[173],"suggesting":[174],"significant":[176],"first-pass":[177],"effect.":[178],"mean":[180,184],"residence":[181],"absorption":[185],"12.3":[190],"(24.3)":[192],"3.1":[194],"(88.1),":[196],"respectively.":[197],"concentration-time":[200],"data":[201],"can":[204],"be":[205],"described":[206],"either":[208],"one-":[210],"or":[211],"two-compartment":[212],"pharmacokinetic":[213],"model.":[214]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}